Control of mouse myoblast commitment to terminal differentiation by mitogens

Area of Science:

• Cell Biology
• Developmental Biology
• Muscle Regeneration

Background:

• Myoblast proliferation and differentiation are crucial for muscle development and repair.
• Fibroblast growth factor (FGF) acts as a mitogen, promoting myoblast proliferation and inhibiting differentiation.
• Understanding the molecular regulation of this transition is key to regenerative medicine.

Purpose of the Study:

• To investigate the regulatory mechanisms controlling the switch from proliferation to terminal differentiation in mouse myoblasts.
• To determine the critical time window and cell cycle phase for irreversible commitment to differentiation.

Main Methods:

• Utilized permanent clonal mouse myoblast cell lines in clonal density cultures.
• Manipulated mitogen (fibroblast growth factor) availability to control proliferation and differentiation.
• Employed 3H-thymidine labeling and autoradiography to analyze cell cycle kinetics and commitment.

Main Results:

• Mouse myoblasts irreversibly commit to terminal differentiation after 2-4 hours of mitogen withdrawal.
• Commitment involves cell cycle withdrawal and initiation of muscle-specific gene expression, including acetylcholine receptors.
• The commitment "decision" is primarily made during the G1 phase of the cell cycle.

Conclusions:

• Mitogen availability dictates the proliferative or differentiative fate of myoblasts.
• A critical period of mitogen deprivation in G1 phase triggers irreversible differentiation commitment.
• This study provides a cell-cycle based model for myoblast differentiation regulation.